And, and what does administration look like? Is there a, a, a treatment window, and, and when does the clock start, and how long does an infusion last?

So an infusion lasts for forty, uh, forty-eight hours, and in the study, we began infusion, uh, before the completion of the mechanical thrombectomy.

We wanted to make sure the drug was on board right at the end of treatment.

Now, given the safety profile that we've seen so far with RNS-60, you can begin treatment earlier But we felt because of the use of our infarct volume growth as a biomarker, we wanted to make sure that we captured an image post-EVT and then starting the drug really right in step with, um, with that new baseline image.

And I think that, that, that design of the study, uh, really benefited us in this situation.

Now, what we've heard from the clinics is that because we provide the bags ready to use, there's no reformulation, um, there's no reconstitution that needs to be done.

You're just simply hanging an IV bag.

When you talk to investors about a non-conventional therapy like this, do you sense extra skepticism or do they approach it the way they would any other experimental drug?